- Home
- AREB vs ALLR Comparison
AREB vs ALLR Comparison
Compare AREB & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREB
- ALLR
- Stock Information
- Founded
- AREB 2014
- ALLR 2004
- Country
- AREB United States
- ALLR United States
- Employees
- AREB N/A
- ALLR N/A
- Industry
- AREB Plastic Products
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- AREB Industrials
- ALLR Health Care
- Exchange
- AREB Nasdaq
- ALLR Nasdaq
- Market Cap
- AREB 3.7M
- ALLR 4.0M
- IPO Year
- AREB N/A
- ALLR N/A
- Fundamental
- Price
- AREB $3.91
- ALLR $1.13
- Analyst Decision
- AREB
- ALLR
- Analyst Count
- AREB 0
- ALLR 0
- Target Price
- AREB N/A
- ALLR N/A
- AVG Volume (30 Days)
- AREB 21.1M
- ALLR 1.4M
- Earning Date
- AREB 04-09-2025
- ALLR 05-13-2025
- Dividend Yield
- AREB N/A
- ALLR N/A
- EPS Growth
- AREB N/A
- ALLR N/A
- EPS
- AREB N/A
- ALLR N/A
- Revenue
- AREB $11,420,268.00
- ALLR N/A
- Revenue This Year
- AREB N/A
- ALLR N/A
- Revenue Next Year
- AREB N/A
- ALLR N/A
- P/E Ratio
- AREB N/A
- ALLR N/A
- Revenue Growth
- AREB N/A
- ALLR N/A
- 52 Week Low
- AREB $1.10
- ALLR $0.61
- 52 Week High
- AREB $231.75
- ALLR $103.80
- Technical
- Relative Strength Index (RSI)
- AREB 44.71
- ALLR 64.89
- Support Level
- AREB $1.80
- ALLR $0.66
- Resistance Level
- AREB $4.79
- ALLR $1.06
- Average True Range (ATR)
- AREB 2.98
- ALLR 0.11
- MACD
- AREB 0.07
- ALLR 0.04
- Stochastic Oscillator
- AREB 16.77
- ALLR 96.31
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic products. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, vault doors, and Others.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.